MichaelT.JarrattMD

Dermatology • Austin, TX

Principal Investigator, DermResearch, Inc, Austin, TX

Join to view full profile

Dr. Jarratt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Jarratt's full profile

Already have an account?

Office
8140 N Mopac Expy
3-120
Austin, TX 78759
Phone+1 512-349-9889
Is this information wrong?

Education & Training

Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 1969 - 1972
Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1966 - 1967
University of Texas Southwestern Medical SchoolClass of 1966

Certifications & Licensure

TX State Medical License 1966 - 2019

Awards, Honors, & Recognition

Top MD Consumers Checkbook
Super Doctor SuperDoctors.com

Clinical Trials

Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail Start of enrollment: 2007 Jan 01
Completed
Phase 2
Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis Start of enrollment: 2007 Feb 01
Completed
Phase 2
Treatment of Androgenetic Alopecia in Females, 9 Beam Start of enrollment: 2009 Oct 01
Completed
Not Applicable
Safety Study of Cosmetic Tissue Augmentation in People of Color Start of enrollment: 2009 Mar 01
Completed
Not Applicable
Dose Response Study of Patients With Erythematous Rosacea Start of enrollment: 2010 Aug 01
Completed
Phase 2
Emervel Classic Lidocaine Versus Juvederm® Ultra in Treatment of Moderate to Severe Facial Wrinkles and Folds Start of enrollment: 2010 Sep 01
Completed
Not Applicable
Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea Start of enrollment: 2011 May 01
Completed
Phase 3
A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis Start of enrollment: 2013 Nov 01
Completed
Phase 3
Study of A-101 for the Treatment of Seborrheic Keratosis Start of enrollment: 2014 Oct 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

8 citations
Pharmacokinetics of ingenol mebutate gel under maximum use conditions in large treatment areas.
Alicia D. Bucko, Michael Jarratt, Dowling B Stough, Laerke Kyhl, John Villumsen, Anders Hall> ;The Journal of Dermatological Treatment. 2018 Jan 2
8 citations
A-101, a Proprietary Topical Formulation of High-Concentration Hydrogen Peroxide Solution: A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of the ...
Janet Dubois, Michael Jarratt, Brian Beger, Mark Bradshaw, Christopher Powala, Stuart D. Shanler> ;Dermatologic Surgery. 2017 Sep 1
5 citations
Lack of significant anti-inflammatory activity with clindamycin in the treatment of rosacea: results of 2 randomized, vehicle-controlled trials.
Philippe Martel, Michael Jarratt, Jonathan S. Weiss, Isabelle Carlavan> ;Cutis. 2017 Apr 1
15 citations
Efficacy of Secukinumab on Moderate-to-severe Plaque Psoriasis Affecting Different Body Regions: a Pooled Analysis of Four Phase 3 Studies.
Alan Menter, Jennifer Clay Cather, Michael Jarratt, Xiangyi Meng, Adriana Guana, Judit Nyirady> ;Dermatology and Therapy. 2016 Aug 30
12 citations
Treatment of facial erythema in patients with rosacea with topical brimonidine tartrate: correlation of patient satisfaction with standard clinical endpoints of improv...
Joseph F. Fowler, Jerry Tan, K Meadows, T Jones, Michael Jarratt, M. Leoni> ;Journal of the European Academy of Dermatology and Venereology. 2015 Mar 1
11 citations
The efficacy and safety of tavaborole, a novel, boron-based pharmaceutical agent: phase 2 studies conducted for the topical treatment of toenail onychomycosis.
Mirna E Toledo-Bahena, Alicia D. Bucko, Jorge Ocampo-Candiani, Maira Elizabeth Herz-Ruelas, Terry M. Jones, Michael Jarratt, Richard Pollak, Lee T Zane> ;Journal of Drugs in Dermatology. 2014 Sep 1
11 citations
Luliconazole for the treatment of interdigital tinea pedis: A double-blind, vehicle-controlled study
Michael Jarratt, Terry Jones, Steven Kempers, Phoebe Rich, Katy Morton, Norifumi Nakamura, Amir Tavakkol> ;Cutis. 2013 Apr 1
12 citations
Tazarotene foam versus tazarotene gel: a randomized relative bioavailability study in acne vulgaris.
Michael Jarratt, Cary P. Werner, Alessandra B Alió Saenz> ;Clinical Drug Investigation. 2013 Mar 1
11 citations
Efficacy and safety of clindamycin-tretinoin gel versus clindamycin or tretinoin alone in acne vulgaris: a randomized, double-blind, vehicle-controlled study.
Michael Jarratt, Tom Brundage> ;Journal of Drugs in Dermatology. 2012 Mar 1
21 citations
Short-term Combination Therapy and Long-Term Relapse Prevention in the Treatment of Severe Acne Vulgaris
Jerry Tan, Stein Gold L, Schlessinger J, Robert T. Brodell, Jones T, Cruz A, Nabil Kerrouche, Michael Jarratt> ;Journal of Drugs in Dermatology. 2012 Feb 1
44 citations
A 6‐month maintenance therapy with adapalene‐benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results...
Yves Poulin, N.P. Sanchez, A. Bucko, Joseph F. Fowler, Michael Jarratt, S. Kempers, Nabil Kerrouche, J.-C. Dhuin, Rod Kunynetz> ;The British Journal of Dermatology. 2011 Jun 1
6 citations
Tretinoin gel microsphere pump 0.04% plus 5% benzoyl peroxide wash for treatment of acne vulgaris: morning/morning regimen is as effective and safe as morning/evening ...
David M. Pariser, Alicia D. Bucko, Richard G. Fried, Michael Jarratt, Steven Kempers, Leon H Kircik, Anne W. Lucky, Elyse S. Rafal, Marta I. Rendon, Jonathan S. Weiss,...> ;Journal of Drugs in Dermatology. 2010 Jul 1
10 citations
Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies.
Lawrence F. Eichenfield, Michael Jarratt, Joel Schlessinger, Steven Kempers, Manna, Joyce Hwa, Yin Liu, Michael Graeber> ;Journal of Drugs in Dermatology. 2010 Jun 1
27 citations
Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular r...
Del Rosso Jq, Bruce S, Michael Jarratt, Menter A, Staedtler G> ;Journal of Drugs in Dermatology. 2010 Jun 1
54 citations
Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies
Peter Foley, Michael Freeman, Alan Menter, Gregory Siller, Rokea A. el-Azhary, Kurt Gebauer, Nicholas J. Lowe, Michael Jarratt, Dedee F. Murrell, Phoebe Rich, David M....> ;International Journal of Dermatology. 2009 Nov 1
123 citations
AJC Editor's Consensus: Psoriasis and Coronary Artery Disease
Vincent E. Friedewald, Jennifer Clay Cather, Joel M. Gelfand, Kenneth B. Gordon, Gary H. Gibbons, Scott M. Grundy, Michael Jarratt, James G. Krueger, Paul M. Ridker, N...> ;The American Journal of Cardiology. 2008 Dec 15
33 citations
Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris.
Warren W. Piette, Susan C. Taylor, David M. Pariser, Michael Jarratt, Pranav B. Sheth, David Wilson> ;Archives of Dermatology. 2008 Dec 15
78 citations
Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, place...
David M. Pariser, Robert Loss, Michael Jarratt, William Abramovits, James M. Spencer, Roy G. Geronemus, Philip L. Bailin, Suzanne Bruce> ;Journal of the American Academy of Dermatology. 2008 Oct 1
41 citations
MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study.
Mark Boguniewicz, Joshua A. Zeichner, Lawrence F. Eichenfield, Adelaide A. Hebert, Michael Jarratt, Anne W. Lucky, Amy S. Paller> ;The Journal of Pediatrics. 2008 Jun 1
14 citations
Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic derma...
William Abramovits, Adelaide A. Hebert, Mark Boguniewicz, Steven Kempers, Eduardo Tschen, Michael Jarratt, Anne W. Lucky, Raymond L. Cornelison, Leonard J. Swinyer, Te...> ;The Journal of Dermatological Treatment. 2008 Jan 1
27 citations
Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis.
Michael Jarratt, Scott D Clark, Ronald C. Savin, Leonard J. Swinyer, Charles F Safley, Robert T. Brodell, Karen Yu> ;Cutis. 2006 Nov 1
18 citations
Combination sodium sulfacetamide 10% and sulfur 5% cream with sunscreens versus metronidazole 0.75% cream for rosacea.
Helen M Torok, Guy F. Webster, Frank Dunlap, Nancy Egan, Michael Jarratt, Daniel Stewart> ;Cutis. 2005 Jun 1
24 citations
Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines.
Michael Jarratt> ;Cutis. 2004 Nov 1
28 citations
Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne.
John J. DiGiovanna, Craig B. Langman, Eduardo Tschen, Terry M. Jones, Alan Menter, Nicholas J. Lowe, Lawrence F. Eichenfield, Adelaide A Hebert, David M. Pariser, Rona...> ;Journal of the American Academy of Dermatology. 2004 Nov 1
75 citations
A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic derm...
Steven Kempers, Mark Boguniewicz, Eric Carter, Michael Jarratt, David M. Pariser, Dan Stewart, Matt Stiller, Eduardo Tschen, Katie Chon, Steve Wisseh, Beatrice Abrams> ;Journal of the American Academy of Dermatology. 2004 Oct 1
Join now to see all